lorazepam glucuronide has been researched along with Pregnancy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertucci, C; da Cunha, SP; da Silva Mathes, Ado C; de Barros Duarte, L; de Carvalho Cavalli, R; Lanchote, VL; Moisés, EC; Papini, O | 1 |
Bertucci, C; da Cunha, SP; Dos Santos, NA; Lanchote, VL; Papini, O | 1 |
Cummings, AJ; Whitelaw, AG | 1 |
2 trial(s) available for lorazepam glucuronide and Pregnancy
Article | Year |
---|---|
Kinetic disposition of lorazepam with focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Chromatography, Liquid; Female; Fetal Blood; Gestational Age; Humans; Lorazepam; Maternal-Fetal Exchange; Parturition; Pregnancy; Spectrometry, Mass, Electrospray Ionization | 2006 |
Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples.
Topics: Acetonitriles; Anti-Anxiety Agents; Chromatography, Liquid; Drug Stability; Female; Humans; Lorazepam; Parturition; Pregnancy; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2006 |
1 other study(ies) available for lorazepam glucuronide and Pregnancy
Article | Year |
---|---|
A study of conjugation and drug elimination in the human neonate.
Topics: Anti-Anxiety Agents; Female; Humans; Hypertension; Infant, Newborn; Lorazepam; Male; Maternal-Fetal Exchange; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Sulfates | 1981 |